Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies

Published: 4 May 2021| Version 1 | DOI: 10.17632/ffx6nd5zyb.1
Contributor:
Daniel Sturm

Description

Supplemental data for an article published in the Journal of the American Academy of Dermatology

Files